Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Philadelphia Personal Injury LawyerDoes Zetia outperform other drugs in reducing cholesterol?
By Jamie Sheller
Zetia, a cholesterol-reducing drug, marketed by Merck and Shering Plough, has recently come under scrutiny by the House Committee on Energy and Commerce. The House is investigating the results of a recent clinical trial of Zetia. This clinical trial was designed to confirm Zetia's ability to reduce the growth of plaque in arteries when combined with another cholesterol drug. Although the clinical trial was conducted in April 2006, the results have yet been released. To read more about this article visit: http://www.nytimes.com/2007/12/12/business/12zetia.html?_r=l&ref=health&oref=slogin
Full post as published by Philadelphia Personal Injury Lawyer on December 12, 2007 (boomark / email).
Merck, Schering
Settle Vytorin Zetia Class Action
GlaxoSmithKline Pays $750 Million Over Defective Drugs
GlaxoSmithKline Pays $750 Million Over Defective Drugs
Fake Drugs
Life Threatening Incidents
Imported Diets
Pills Contain Illegal Drugs
Florida Medicaid
Limiting Coverage of Drugs for Kids
FDA
Halts Importation of Drugs Manufactured Offshore By Ranbaxy

Ezetrol: Zetia by Any Other Name…
Drug Makers Release Test Results That Shows That Their Cholesterol Drug Zetia Has No Benefits
Vytorin and Zetia May Not Work: Cardiologists
Zetia/Vytorin: “He was a good man and his life was cut short.”
Merck withheld Zetia data about liver damage
Drug Companies Pull Vytorin TV Ad








